[EN] MASP INHIBITORY COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS INHIBITEURS DE MASP ET LEURS UTILISATIONS
申请人:BAYER AG
公开号:WO2020225095A1
公开(公告)日:2020-11-12
The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.
本发明涉及新型甘霖结合凝集素(MBL)相关丝氨酸蛋白酶(MASP)抑制化合物,以及其类似物和衍生物,以及其制备方法,单独或组合用于治疗和/或预防疾病,以及用于生产药物治疗和/或预防疾病,特别是用于治疗和/或预防肾脏和心血管疾病以及缺血再灌注损伤。